Under fire, Pfizer hits back as it weighs next Astra move

[Reuters] – U.S. drugmaker Pfizer (PFE) fought back on Saturday against criticism that its planned takeover of rival AstraZeneca (AZN.L) would damage Britain’s science base by saying strong UK research was a key reason for the deal. Given its record of b more

View todays social media effects on PFE

View the latest stocks trending across Twitter. Click to view dashboard

See who Pfizer is hiring next, click here to view